501 related articles for article (PubMed ID: 18383951)
21. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
[TBL] [Abstract][Full Text] [Related]
22. Assessment of cardiac and hepatic iron overload in thalassaemic patients by magnetic resonance: a four year observational study.
Candini G; Lappi S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():204-7. PubMed ID: 19337179
[TBL] [Abstract][Full Text] [Related]
23. [Quantification of iron overload].
Guyader D; Gandon Y
Bull Acad Natl Med; 2000; 184(2):337-47; discussion 347-8. PubMed ID: 10989542
[TBL] [Abstract][Full Text] [Related]
24. One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients.
Lam WW; Au WY; Chu WC; Tam S; Ha SY; Pennell DJ
J Magn Reson Imaging; 2008 Jul; 28(1):29-33. PubMed ID: 18581349
[TBL] [Abstract][Full Text] [Related]
25. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.
Di Tucci AA; Matta G; Deplano S; Gabbas A; Depau C; Derudas D; Caocci G; Agus A; Angelucci E
Haematologica; 2008 Sep; 93(9):1385-8. PubMed ID: 18603557
[TBL] [Abstract][Full Text] [Related]
26. Iron overload: consequences, assessment, and monitoring.
Taher AT; Musallam KM; Inati A
Hemoglobin; 2009; 33 Suppl 1():S46-57. PubMed ID: 20001632
[TBL] [Abstract][Full Text] [Related]
27. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
Au WY; Lam WW; Chu W; Tam S; Wong WK; Liang R; Ha SY
Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
[TBL] [Abstract][Full Text] [Related]
28. [Iron accumulation in the liver of patients with thalassemia major assessed with low field strength magnetic resonance: correlation with clinico-instrumental parameters].
Di Renzi P; Cianciulli P; Preziosi P; Amadori S; Orlacchio A
Radiol Med; 1996 Jun; 91(6):764-8. PubMed ID: 8830363
[TBL] [Abstract][Full Text] [Related]
29. Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload.
Meloni A; Luciani A; Positano V; De Marchi D; Valeri G; Restaino G; Cracolici E; Caruso V; Dell'amico MC; Favilli B; Lombardi M; Pepe A
J Magn Reson Imaging; 2011 Feb; 33(2):348-55. PubMed ID: 21274976
[TBL] [Abstract][Full Text] [Related]
30. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
[TBL] [Abstract][Full Text] [Related]
31. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y
Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
[TBL] [Abstract][Full Text] [Related]
32. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
Wahidiyat PA; Iskandar SD; Sekarsari D
Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging and different levels of iron overload in chronic liver disease.
Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Casalgrandi G; Burani A; Gallo E
Hepatology; 1993 Jun; 17(6):997-1002. PubMed ID: 8514272
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
[TBL] [Abstract][Full Text] [Related]
36. MRI and iron-overload cardiomyopathy in thalassaemia.
Pennell D
Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
[No Abstract] [Full Text] [Related]
37. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Majhail NS; DeFor T; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
[TBL] [Abstract][Full Text] [Related]
38. The uses and differences of r2 and r2* in the determination of iron overload in iron loaded thalassemia patients.
Gotsis ED
Hemoglobin; 2008; 32(1-2):75-83. PubMed ID: 18274985
[TBL] [Abstract][Full Text] [Related]
39. Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.
Fernandes JL; Sampaio EF; Fertrin K; Coelho OR; Loggetto S; Piga A; Verissimo M; Saad ST
Am J Med; 2013 Sep; 126(9):834-7. PubMed ID: 23830536
[TBL] [Abstract][Full Text] [Related]
40. [Secondary hepatic hemochromatosis: diagnosis and quantification with 0.5 T magnetic resonance. Value and limitations].
Tamburrini O; Andò S; Della Sala M; Maggiolini M; Sessa M
Radiol Med; 1993 Dec; 86(6):841-6. PubMed ID: 8296005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
